Welcome to the Bacteriophage Therapy Summit!
The definitive gathering of global phage experts across disciplines and industries. Focusing on human health and disease, advance your phage-based therapies through clinical development and commercialization beyond compassionate use.
Our 2022 summit united 35+ expert speakers from the FDA, BiomX, Locus Bioscience, Felix Biotechnology, Phagomed, PhagePro, Cytophage, Sciphage and more.
Understand planning of regulatory frameworks
for phage therapeutics and the manufacturing questions arising from stability and long-term safety with the FDA and BiomX to drive the approval of commercial bacteriophages
Investigate factors affecting efficacy of clinical trials
by taking a deep dive into successful pairings of phages to bacteria with members of the ESGNTA and overcome challenges in infection specific patient treatments
Accelerate formulation and manufacturing of phages for commercial use
by understanding quality-by-design and exploitation of dark matter approaches in phage genomes with Loughborough University and the University of Helsinki for better process optimization and development of new antibiotics
Discover the importance of clinical trial design
by joining international surgeons and clinicians investigating targeting antimicrobial resistance for various infections through tailored clinical design and rationale
Utilize genomic data using technology to predict host ranges
with BiomX, build universal phage platforms with Uniphage, and determine the phages a patient requires on a routine basis with Vesale Pharma, to select the best phage for specific scenarios